Aceso Life Science Group (474) Stock Overview
An investment holding company, engages in the financial services, property leasing and development, and construction machinery businesses in Hong Kong and the United Kingdom. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
474 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Aceso Life Science Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.13 |
| 52 Week High | HK$0.14 |
| 52 Week Low | HK$0.018 |
| Beta | -0.46 |
| 1 Month Change | 7.50% |
| 3 Month Change | 13.16% |
| 1 Year Change | 174.47% |
| 3 Year Change | -25.86% |
| 5 Year Change | -43.91% |
| Change since IPO | -96.82% |
Recent News & Updates
Shareholder Returns
| 474 | HK Consumer Finance | HK Market | |
|---|---|---|---|
| 7D | 9.3% | 1.9% | -0.8% |
| 1Y | 174.5% | 103.8% | 21.5% |
Return vs Industry: 474 exceeded the Hong Kong Consumer Finance industry which returned 102.2% over the past year.
Return vs Market: 474 exceeded the Hong Kong Market which returned 22.5% over the past year.
Price Volatility
| 474 volatility | |
|---|---|
| 474 Average Weekly Movement | 7.5% |
| Consumer Finance Industry Average Movement | 6.5% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in HK Market | 13.9% |
| 10% least volatile stocks in HK Market | 2.9% |
Stable Share Price: 474 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 474's weekly volatility has decreased from 22% to 7% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 41 | n/a | www.acesogrouphk.com |
Aceso Life Science Group Limited, an investment holding company, engages in the financial services, property leasing and development, and construction machinery businesses in Hong Kong and the United Kingdom. It operates through rental and sale of construction machinery and spare parts business; provision of repair and maintenance and transportation service business; money lending business; provision of asset management, securities brokerage and other financial service business; property leasing business; and property development business segments. The company leases and sells construction machinery, including crawler cranes, mobile cranes, aerial platforms, and foundation equipment, as well as spare parts; and sells construction materials.
Aceso Life Science Group Limited Fundamentals Summary
| 474 fundamental statistics | |
|---|---|
| Market cap | HK$952.25m |
| Earnings (TTM) | -HK$395.00m |
| Revenue (TTM) | n/a |
Is 474 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 474 income statement (TTM) | |
|---|---|
| Revenue | -HK$56.00m |
| Cost of Revenue | HK$105.00m |
| Gross Profit | -HK$161.00m |
| Other Expenses | HK$234.00m |
| Earnings | -HK$395.00m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.054 |
| Gross Margin | 287.50% |
| Net Profit Margin | 705.36% |
| Debt/Equity Ratio | 330.3% |
How did 474 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/17 06:48 |
| End of Day Share Price | 2026/02/16 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Aceso Life Science Group Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Martin Wang | Guotai Junan International Holdings Limited |